Status:
COMPLETED
HI-VISION Pilot Study
Lead Sponsor:
McMaster University
Collaborating Sponsors:
Hamilton Health Sciences Corporation
Conditions:
Postoperative Hypoxia
Eligibility:
All Genders
45+ years
Brief Summary
A prospective cohort pilot study of non-cardiac patients to determine the feasibility of recruiting 150 patients to undergo postoperative continuous hemodynamic monitoring for up to 3 days.
Detailed Description
Patient will start wearing the Philips' hemodynamic and ECG monitor in the Post Anaesthesia Care Unit (PACU). This device will continuously measure heart rate, pulse oxymetry, and ST-segments. The dev...
Eligibility Criteria
Inclusion
- We will enroll patients aged 45 years or older undergoing noncardiac surgery who fulfilled 2 or more of the following risk factors:
- History of coronary artery disease
- History of stroke or transient ischemic attack (TIA)
- History of hypertension
- History of diabetes
- History of peripheral vascular disease
- History of congestive heart failure
- Preoperative creatinine \> 175 umol/L
- A planned admission for ≥48 hours
- Patients receiving a general or regional anesthetic
Exclusion
- Patients unable to provide informed consent.
- Patients who undergo procedure performed under infiltrative or topical anesthesia.
- Patients previously enrolled in the HI-VISION Study.
- Patients who refuse 30-day follow-up.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT02300441
Start Date
September 1 2014
End Date
September 1 2015
Last Update
April 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Juravinski Hospital
Hamilton, Ontario, Canada, L8V5C2